ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
ISPOR Membership: Becoming an ISPOR member offers unique advantages in health economics and outcomes research (HEOR). Members gain valuable benefits, global networking opportunities, and platforms for advancing HEOR excellence, joining nearly 18,000 professionals across 100+ countries who are dedicated to improving healthcare decision making worldwide. https://www.ispor.org/membership
HEOR Learning Lab™ is ISPOR’s on-demand educational resource, offering unlimited video content from conferences and events. Covering key topics like real-world evidence, digital health, AI, and health policy, it supports continuous learning for HEOR professionals and interested learners worldwide. https://www.ispor.org/welcome-HEOR-Learning-Lab
ISPOR VIDEOS
-
Join us to see how HEOR drives impact across the global healthcare landscape.
-
This video features expert insights into the evolving landscape of Patient-Centered Research and the role of HEOR in risk-benefit assessments.
-
Stay at the forefront of digital innovation in healthcare and understand how artificial intelligence is revolutionizing Health Economics and Outcomes Research (HEOR) in this insightful video.
-
Whole health looks beyond traditional care by addressing food access, environment, and lived experiences—leading to healthier communities and more holistic outcomes.
-
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.
-
Review the ripple effects of drug price controls, including recent U.S. policy shifts like the IRA and President Trump’s Executive Order introducing International Reference Pricing.
CONTACT INFORMATION
ISPOR—The Professional Society for Health Economics and Outcomes Research
505 Lawrence Square Blvd South
Lawrenceville, NJ 08648
UNITED STATES
Phone: (609) 691-8942
Contact: Michelle Rovner
FEATURED ARTICLES
-
Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
See late‑2025 policy actions, including international pricing agreements, new payment models, and global regulatory changes, while previewing key themes expected to shape 2026 health policy.
-
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
-
The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
This report outlines ten defining HEOR trends influencing global health decision-making.
-
Health Economics and Outcomes Research (HEOR) plays a vital role in guiding evidence-based decisions across the healthcare ecosystem.